Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial (Q41922839)
Jump to navigation
Jump to search
scientific article published on 6 October 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial |
scientific article published on 6 October 2017 |
Statements
1 reference
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial (English)
1 reference
1 reference
Peter G Kremsner
1 reference
Martin P Grobusch
1 reference
Benjamin Mordmüller
1 reference
Bertrand Lell
1 reference
Verena Krähling
1 reference
Marie-Paule Kieny
1 reference
Stephan Becker
1 reference
Selidji T Agnandji
1 reference
José F Fernandes
1 reference
Emmanuel B Bache
1 reference
Régis M Obiang Mba
1 reference
Jessica S Brosnahan
1 reference
Lumeka Kabwende
1 reference
Paul Pitzinger
1 reference
Pieter Staarink
1 reference
Marguerite Massinga-Loembe
1 reference
Nadine Biedenkopf
1 reference
Sarah Katharina Fehling
1 reference
Thomas Strecker
1 reference
David J Clark
1 reference
Jay W Hooper
1 reference
Peter Silvera
1 reference
Akim A Adegnika
1 reference
VEBCON Consortium
1 reference
6 October 2017
1 reference
2 references
Identifiers
1 reference